Amelia Evoli Selected Research

Myasthenia Gravis

1/2022	Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study.
1/2022	Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis.
1/2022	Neurophysiological challenges in myasthenia gravis associated with MuSK antibodies: a case report.
1/2022	Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders.
10/2021	Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection.
5/2021	In sickness and in health: when myasthenia gravis is a conjugal matter.
5/2021	Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?
4/2021	Benefit and danger from immunotherapy in myasthenia gravis.
1/2021	Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis.
1/2021	Heterogeneity in myasthenia gravis: considerations for disease management.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amelia Evoli Research Topics

Disease

59	Myasthenia Gravis 01/2022 - 01/2002
10	Thymoma (Thymic Carcinoma) 01/2021 - 09/2005
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2002
4	Muscle Weakness 01/2019 - 09/2002
3	Autoimmune Diseases of the Nervous System 01/2021 - 10/2017
3	Neuromyelitis Optica (Devic's Disease) 01/2017 - 09/2013
3	Neoplasms (Cancer) 08/2014 - 08/2009
2	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 01/2022 - 01/2006
2	COVID-19 01/2022 - 10/2021
2	Cognitive Dysfunction 04/2019 - 12/2009
2	Respiratory Insufficiency (Respiratory Failure) 01/2019 - 04/2014
2	Rare Diseases (Rare Disease) 01/2018 - 07/2013
2	Transverse Myelitis (Necrotizing Myelitis) 09/2014 - 09/2013
2	Isaacs Syndrome (Neuromyotonia) 09/2014 - 01/2006
2	Hepatitis C 03/2007 - 01/2002
1	Neuromuscular Junction Diseases 01/2022
1	Late Onset Disorders 05/2021
1	Thyroiditis 05/2021
1	Ulcerative Colitis 05/2021
1	Fasciculation (Fasciculations) 01/2021
1	Muscle Cramp (Cramp) 01/2021
1	Disease Progression 01/2020
1	Fatigue 04/2019
1	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 03/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2019
1	Rheumatoid Arthritis 01/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2018
1	Rheumatic Diseases (Rheumatism) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 09/2014
1	Carcinoma (Carcinomatosis) 08/2014
1	Myelitis 09/2013
1	Neonatal Myasthenia Gravis (Transient Neonatal Myasthenia Gravis) 10/2010
1	Thymus Hyperplasia 08/2009
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2006

Drug/Important Bio-Agent (IBA)

29	AntibodiesIBA 01/2022 - 09/2002
24	Cholinergic ReceptorsIBA 01/2022 - 09/2003
22	muskIBA 01/2022 - 01/2008
12	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021 - 01/2008
10	AutoantibodiesIBA 01/2022 - 09/2002
9	Rituximab (Mabthera)FDA Link 01/2020 - 12/2012
6	Phosphotransferases (Kinase)IBA 01/2022 - 10/2010
5	Immunoglobulin G (IgG)IBA 01/2020 - 09/2013
5	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2002
4	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 10/2021 - 10/2003
4	Prednisone (Sone)FDA LinkGeneric 11/2020 - 09/2005
4	Proteins (Proteins, Gene)FDA Link 03/2019 - 09/2014
3	SteroidsIBA 01/2020 - 01/2002
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 08/2009
3	AntigensIBA 10/2017 - 09/2002
3	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2015 - 09/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2013
2	Cholinergic Agents (Cholinergics)IBA 01/2021 - 12/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021 - 01/2019
2	margatoxinIBA 11/2020 - 01/2019
2	Monoclonal AntibodiesIBA 01/2020 - 01/2018
2	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 09/2014 - 01/2006
2	Azathioprine (Imuran)FDA LinkGeneric 09/2005 - 01/2002
1	COVID-19 VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	HLA-DRB1*07 antigenIBA 05/2021
1	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	NSC-87877IBA 01/2020
1	neonatal Fc receptorIBA 01/2019
1	Edrophonium (Tensilon)FDA LinkGeneric 01/2019
1	Immunoglobulin Fc FragmentsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2019
1	glucose-mannose-glucoseIBA 01/2019
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2018
1	Surface Antigens (Surface Antigen)IBA 10/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2017
1	ruxolitinibIBA 03/2017
1	AmifampridineIBA 03/2016
1	MicroRNAs (MicroRNA)IBA 03/2016
1	EpitopesIBA 02/2016
1	AutoantigensIBA 01/2016
1	LDL Receptors (LDL Receptor)IBA 05/2015
1	Immunomodulating AgentsIBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 04/2015
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2014
1	Vascular Endothelial Growth FactorsIBA 08/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 04/2014
1	Aquaporins (Water Channels)IBA 09/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2013
1	Imatinib Mesylate (Gleevec)FDA Link 02/2012
1	AcetylcholinesteraseIBA 01/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2008
1	Ribavirin (Virazole)FDA LinkGeneric 03/2007

Therapy/Procedure

12	Therapeutics 01/2021 - 01/2008
9	Thymectomy 11/2020 - 09/2005
4	Immunotherapy 01/2022 - 09/2014
1	Plasma Exchange 01/2019
1	Activities of Daily Living (ADL) 01/2019
1	Critical Care (Surgical Intensive Care) 01/2019
1	Plasmapheresis 04/2014
1	Sternotomy 06/2009